The efficacy and safety of Sanqi Qushi Granule in patients with idiopathic membranous nephropathy --protocol of a multicenter, randomized control trial (SQ-AUTUMN)
Abstract Background Adult nephropathy is mainly caused by idiopathic membranous nephropathy (IMN). In cases of proteinuria, Modified Ponticelli Regimens (MPR) are often successful. However, it can cause adverse side effects. Oral Sanqi Qushi Granule (SQG) with MPR is effective in patients with IMN....
Saved in:
Main Authors: | Chuang Li (Author), Wenjun Shan (Author), Xing Liang (Author), Qinghua Zhang (Author), Xindong Qin (Author), Sha Jiang (Author), Xiaofan Hong (Author), Lijuan Wang (Author), Ping Li (Author), Haowen Gu (Author), Yi Wang (Author), Kun Bao (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2023-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Sanqi Qushi Granule Alleviates Proteinuria and Podocyte Damage in NS Rat: A Network Pharmacology Study and in vivo Experimental Validation
by: Wang L, et al.
Published: (2023) -
Metabonomic Analysis of the Therapeutic Effects of Chinese Medicine Sanqi Oral Solution on Rats With Exhaustive Exercise
by: Peng Xu, et al.
Published: (2019) -
Sanqi Oral Solution Ameliorates Renal Ischemia/Reperfusion Injury via Reducing Apoptosis and Enhancing Autophagy: Involvement of ERK/mTOR Pathways
by: Ruimin Tian, et al.
Published: (2020) -
Sanqi Oral Solution Mitigates Proteinuria in Rat Passive Heymann Nephritis and Blocks Podocyte Apoptosis via Nrf2/HO-1 Pathway
by: Xiaowan Wang, et al.
Published: (2021) -
Corrigendum: Sanqi Oral Solution Mitigates Proteinuria in Rat Passive Heymann Nephritis and Blocks Podocyte Apoptosis via Nrf2/HO-1 Pathway
by: Xiaowan Wang, et al.
Published: (2022)